Greenfern Industries nombra a Kirsten Taylor presidente de la junta y CEO de Elizabeth Plant para impulsar el crecimiento del cannabis medicinal. Greenfern Industries names Kirsten Taylor board chair and Elizabeth Plant CEO to drive medicinal cannabis growth.

Greenfern Industries, una compañía de cannabis medicinal neozelandesa, ha nombrado a Kirsten Taylor como su nueva presidenta y a Elizabeth Plant como CEO. Greenfern Industries, a New Zealand medicinal cannabis company, has appointed Kirsten Taylor as its new board chair and Elizabeth Plant as CEO. Taylor aporta experiencia en gobernanza e innovación de productos, mientras que Plant, ex director médico de EQALIS Pharmaceuticals, tiene una amplia experiencia en salud. Taylor brings expertise in governance and product innovation, while Plant, formerly Chief Medical Officer at EQALIS Pharmaceuticals, has extensive healthcare experience. Su objetivo es ampliar las corrientes de ingresos y desarrollar productos innovadores de cannabis medicinal. They aim to expand revenue streams and develop innovative medicinal cannabis products.